Elevated Beta-Hydroxybutyrate: Clinical Manifestations
Elevated beta-hydroxybutyrate (β-OHB) causes metabolic acidosis with ketonemia, leading to a spectrum of clinical manifestations ranging from altered mental status (drowsiness to coma), Kussmaul respirations, dehydration, abdominal pain, nausea/vomiting, and in severe cases, cardiovascular collapse and death.
Primary Clinical Context: Diabetic Ketoacidosis (DKA)
The most critical clinical syndrome associated with elevated β-OHB is diabetic ketoacidosis, where β-OHB is the predominant and strongest ketone body produced 1. The pathophysiology involves insulin deficiency combined with elevated counterregulatory hormones (glucagon, catecholamines, cortisol, growth hormone), leading to unrestrained lipolysis and hepatic fatty acid oxidation to ketone bodies 1.
Key Clinical Manifestations by System:
Neurological:
- Mental status changes ranging from full alertness → drowsiness → stupor → coma
- Severity correlates with degree of metabolic derangement
- More profound alterations occur with concurrent hyperosmolar states 1
Respiratory:
- Kussmaul respirations (deep, labored breathing) - compensatory response to metabolic acidosis
- Present specifically in DKA, not in hyperosmolar hyperglycemic state (HHS) 1
Gastrointestinal:
- Abdominal pain (occurs in DKA, distinguishing it from HHS) 1
- Nausea and vomiting (up to 25% of patients)
- Coffee-ground emesis with hemorrhagic gastritis on endoscopy 1
Cardiovascular:
- Tachycardia
- Hypotension progressing to shock
- Peripheral vasodilation leading to normothermia or hypothermia despite infection 1
- Critical caveat: Hypothermia is a poor prognostic sign associated with increased mortality 1
Metabolic/Constitutional:
- Polyuria, polydipsia, polyphagia
- Weight loss
- Dehydration with poor skin turgor
- Weakness 1
Diagnostic Thresholds
β-OHB is the preferred biomarker for monitoring ketoacidosis because traditional nitroprusside methods only detect acetoacetate and acetone, missing the predominant ketone 1. During treatment, β-OHB converts to acetoacetate, which can falsely suggest worsening ketosis if using nitroprusside testing 1.
DKA Diagnostic Criteria (with elevated β-OHB):
- Plasma glucose >250 mg/dL
- Arterial pH <7.30
- Serum bicarbonate <18 mEq/L
- Positive serum ketones (β-OHB elevated)
- Anion gap >10 mEq/L 1
Alternative Causes of Elevated β-OHB
Starvation Ketosis:
- Mild elevation of β-OHB
- Bicarbonate usually not <18 mEq/L
- Distinguished by clinical history and glucose levels (not markedly elevated) 1
Alcoholic Ketoacidosis:
- Can cause profound acidosis similar to DKA
- Glucose ranges from mildly elevated to hypoglycemic (rarely >250 mg/dL)
- Distinguished by history of alcohol abuse and glucose levels 1
Prognostic Implications
Recent research demonstrates that elevated β-OHB has prognostic significance beyond acute ketoacidosis:
- Cardiovascular disease: Elevated β-OHB predicts major adverse cardiac events (MACE) in acute myocardial infarction patients and arrhythmogenic cardiomyopathy 2, 3
- Mortality marker: β-OHB >1000 μmol/L with appropriate pathophysiological conditions can indicate death from ketoacidosis when autopsy findings are inconclusive 4
- DKA risk stratification: Each 0.1 mmol/L increase in baseline β-OHB increases DKA risk by 18%, independent of treatment 5
Critical Clinical Pitfalls
Do not rely on urine ketone testing alone - it misses β-OHB and shows poor concordance (24% discordant results), particularly in patients with renal dysfunction 6
Monitor for precipitating factors - infection is the most common trigger, but also consider cerebrovascular accident, myocardial infarction, pancreatitis, trauma, and medications (corticosteroids, thiazides, sympathomimetics) 1
Recognize that ketonemia clears slower than hyperglycemia - continue monitoring β-OHB even after glucose normalizes 1
Elderly patients and those in chronic care facilities are at particular risk for developing severe hyperglycemic states with elevated β-OHB when unable to maintain adequate hydration 1